For 2025, our focus remains: translating new data into clinical practice. The programme will consist of state-of-the-art lectures, case discussions and panel debates. Our faculty is a group of well-chosen international & multidisciplinary experts, who will discuss all hot topics of 2025 in renal, prostate and bladder cancer. There are no parallel sessions in order to maximise interaction.

We will take you on our journey to Lisbon and beyond. Prior to the meetings, we send out case challenges, where you can compare your opinion with peers & experts. These cases will be part of the RENALC-BLADDR-PROSCA programme during the meetings (3 December for RENALC, 3 & 4 December for BLADDR and 5 & 6 December for PROSCA). After the meetings, you will be fully updated on renal, prostate & bladder cancer management.

Day 1 - PROSCA - Wednesday 

3 December 2025 at 08:30 — 23 December 2025 at 08:45
Official opening

Arnaldo Figueiredo, José Luís Passos Coelho

3 December 2025 at 08:45 — 3 December 2025 at 10:00
Advancements in imaging and local disease management

Moderator: Arnaldo Figueiredo, Lisa Pickering

  • Imaging innovations in RCC - Pieter De Visschere
  • Debate: Management of T1 tumours - Axel Bex, Riccardo Campi, Peter Hoskin, Géraldine Pignot
  • Emerging neoadjuvant treatment approaches - Axel Bex
  • Case presentation - Teele Kuusk
  • Panel discussion and Q&A

Day 2 - BLADDR

3 December 2025 at 08:45 — 3 December 2025 at 10:00
Advancements in imaging and local disease management

Moderator: Arnaldo Figueiredo, Lisa Pickering

  • Imaging innovations in RCC - Pieter De Visschere
  • Debate: Management of T1 tumours - Axel Bex, Riccardo Campi, Peter Hoskin, Géraldine Pignot
  • Emerging neoadjuvant treatment approaches - Axel Bex
  • Case presentation - Teele Kuusk
  • Panel discussion and Q&A